Cargando…

Epigallocatechin-3 Gallate Inhibits STAT-1/JAK2/IRF-1/HLA-DR/HLA-B and Reduces CD8 MKG2D Lymphocytes of Alopecia Areata Patients

Background: Alopecia areata (AA) is associated with Interferon- γ (IFN-γ) mediated T-lymphocyte dysfunction and increased circulating Interleukine-17 (IL-17) levels. Epigallocatechin-3-gallate (EGCG) specifically inhibits IFN-γ pathways and unlike Janus Kinase 1 and 2 (JAK1/JAK2) inhibitors (tofacit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hamed, Fatma N., McDonagh, Andrew J. G., Almaghrabi, Sarah, Bakri, Youssef, Messenger, Andrew G., Tazi-Ahnini, Rachid
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6313664/ https://www.ncbi.nlm.nih.gov/pubmed/30558329 http://dx.doi.org/10.3390/ijerph15122882

Ejemplares similares

Alopecia areata patients show deficiency of FOXP(3)+CD(39)+ T regulatory cells and clonotypic restriction of Treg TCRβ-chain, which highlights the immunopathological aspect of the disease
por: Hamed, Fatma N., et al.
Publicado: (2019)

Correction: Alopecia areata patients show deficiency of FOXP(3)+CD(39)+ T regulatory cells and clonotypic restriction of Treg TCRβ-chain, which highlights the immunopathological aspect of the disease
por: Hamed, Fatma N., et al.
Publicado: (2019)

The AIRE -230Y Polymorphism Affects AIRE Transcriptional Activity: Potential Influence on AIRE Function in the Thymus
por: Lovewell, Thomas R. J., et al.
Publicado: (2015)

Meta-Analysis of Autoimmune Regulator-Regulated Genes in Human and Murine Models: A Novel Human Model Provides Insights on the Role of Autoimmune Regulator in Regulating STAT1 and STAT1-Regulated Genes
por: Lovewell, Thomas R. J., et al.
Publicado: (2018)

Whole Genome Sequencing in an Acrodermatitis Enteropathica Family from the Middle East
por: Abu-Duhier, Faisel, et al.
Publicado: (2018)

An overview of JAK/STAT pathways and JAK inhibition in alopecia areata
por: Lensing, Maddison, et al.
Publicado: (2022)

A Comment on JAK Inhibitors for Treatment of Alopecia Areata
por: Trüeb, Ralph Michel, et al.
Publicado: (2018)

Lack of association between alopecia areata and HLA class I and II in a southeastern Brazilian population
por: Barbosa, Ângela Marques, et al.
Publicado: (2016)

HLA-DRB1 polymorphisms and alopecia areata disease risk: A systematic review and meta-analysis
por: Ji, Conghua, et al.
Publicado: (2018)

AAV9‐mediated AIRE gene delivery clears circulating antibodies and tissue T‐cell infiltration in a mouse model of autoimmune polyglandular syndrome type‐1
por: Almaghrabi, Sarah, et al.
Publicado: (2020)

Translational Positioning of Janus Kinase (JAK) Inhibitors in Alopecia Areata
por: Blume-Peytavi, Ulrike, et al.
Publicado: (2015)

Serum Interleukin-4 and Total Immunoglobulin E in Nonatopic Alopecia Areata Patients and HLA-DRB1 Typing
por: Attia, Enas A. S., et al.
Publicado: (2010)

Genome-wide meta-analysis in alopecia areata resolves HLA associations and reveals two new susceptibility loci
por: Betz, Regina C., et al.
Publicado: (2015)

A Comprehensive Literature Review of JAK Inhibitors in Treatment of Alopecia Areata
por: Dillon, Kerry-Ann L
Publicado: (2021)

Selective inhibition of JAK3 signaling is sufficient to reverse alopecia areata
por: Dai, Zhenpeng, et al.
Publicado: (2021)

Alopecia Areata
Publicado: (1908)

Alopecia Areata
por: Reid, Thomas
Publicado: (1869)

Alopecia Areata
por: Spangenthal, Joseph
Publicado: (1898)

Characterisation of APS-1 Experimental Models Is Crucial for Development of Novel Therapies
por: Almaghrabi, Sarah, et al.
Publicado: (2023)

Reversal of Alopecia Areata Following Treatment With the JAK1/2 Inhibitor Baricitinib
por: Jabbari, Ali, et al.
Publicado: (2015)

Induction of T cell exhaustion by JAK1/3 inhibition in the treatment of alopecia areata
por: Dai, Zhenpeng, et al.
Publicado: (2022)

Management of Alopecia Areata With Topical JAK Inhibitor Therapy: An Evidence-Based Review
por: Abduelmula, Abrahim, et al.
Publicado: (2022)

Management of alopecia areata
por: Harries, M J, et al.
Publicado: (2010)

Alopecia areata incognita
por: Molina, Luciana, et al.
Publicado: (2011)

IS ALOPECIA AREATA PSYCHOSOMATIC ?
por: Devar, J.V.
Publicado: (1983)

Linear Alopecia Areata
por: Shetty, Shricharith, et al.
Publicado: (2016)

Ringworm and Alopecia Areata
Publicado: (1898)

The Etiology of Alopecia Areata
Publicado: (1904)

Linear alopecia areata
por: Yu, Lijuan, et al.
Publicado: (2018)

The Fungus of Alopecia Areata
Publicado: (1874)

Immunology of alopecia areata
por: ŻEBERKIEWICZ, MARTA, et al.
Publicado: (2020)

The Naming of Alopecia Areata
por: Montgomery, Douglass W.
Publicado: (1931)

Immunopathogenesis of alopecia areata
por: Olayinka, Jadesola (Jadé) Temitope, et al.
Publicado: (2021)

Effect of (−)-Epigallocatechin Gallate on Activation of JAK/STAT Signaling Pathway by Staphylococcal Enterotoxin A
por: Shimamura, Yuko, et al.
Publicado: (2021)

Which is the Ideal JAK Inhibitor for Alopecia Areata – Baricitinib, Tofacitinib, Ritlecitinib or Ifidancitinib - Revisiting the Immunomechanisms of the JAK Pathway
por: Sardana, Kabir, et al.
Publicado: (2023)

Alopecia Areata Mimicking Frontal Fibrosing Alopecia
por: Trindade de Carvalho, Lara, et al.
Publicado: (2021)

Perinevoid Alopecia: an Unusual Presentation of Alopecia Areata
por: Machado, José Leonardo Rodrigues, et al.
Publicado: (2022)

Alopecia Areata – Probing the Deforestation
por: Gude, Dilip
Publicado: (2011)

UTILITY OF DERMOSCOPY IN ALOPECIA AREATA
por: Mane, Mandar, et al.
Publicado: (2011)

Topical Immunotherapy in Alopecia Areata
por: Singh, Gurcharan, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_5pqib2lplpeeflmhce7nd1dubd